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Abstract
Iodine-123 mIBG imaging is widely regarded as a gold standard for diagnostic 
studies of neuroblastoma and adult neuroendocrine cancer although the 
optimal collimator for tumour imaging remains undetermined. Low-energy 
(LE) high-resolution (HR) collimators provide superior spatial resolution. 
However due to septal penetration of high-energy photons these provide 
poorer contrast than medium-energy (ME) general-purpose (GP) collimators. 
LEGP collimators improve count sensitivity. The aim of this study was to 
objectively compare the lesion detection efficiency of each collimator to 
determine the optimal collimator for diagnostic imaging.
The septal penetration and sensitivity of each collimator was assessed. 
Planar images of the patient abdomen were simulated with static scans of a 
Liqui-Phil™ anthropomorphic phantom with lesion-shaped inserts, acquired 
with LE and ME collimators on 3 different manufacturers’ gamma camera 
systems (Skylight (Philips), Intevo (Siemens) and Discovery (GE)). Two-
hundred normal and 200 single-lesion abnormal images were created for 
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each collimator. A channelized Hotelling observer (CHO) was developed 
and validated to score the images for the likelihood of an abnormality. The 
areas under receiver-operator characteristic (ROC) curves, Az, created from 
the scores were used to quantify lesion detectability. The CHO ROC curves 
for the LEHR collimators were inferior to the GP curves for all cameras. The 
LEHR collimators resulted in statistically significantly smaller Azs (p  <  0.05), 
of on average 0.891  ±  0.004, than for the MEGP collimators, 0.933  ±  0.004. 
In conclusion, the reduced background provided by MEGP collimators 
improved 123I mIBG image lesion detectability over LEHR collimators that 
provided better spatial resolution.
Keywords: iodine-123, neuroblastoma, collimator, channelized Hotelling 
observer, lesion detectability
(Some figures may appear in colour only in the online journal)
Introduction
Radionuclide imaging with Metaiodobenzylguanidine (mIBG) has a fundamental role in 
the diagnosis, staging and evaluation of treatment response in childhood neuroblastoma and 
adult neuroendocrine tumours (NETs) (Gelfand 1993, Shapiro et al 2001, Brisse et al 2011). 
Scintigraphy is routinely undertaken using 123I-mIBG in preference to 131I-mIBG, because 
better quality images can be obtained from 159 keV 123I gamma photons and twenty times 
more 123I activity can be administered for diagnostic scans (Shapiro et  al 1987, Matthay 
et al 2010). Iodine-123 is also advocated for treatment planning prior to 131I mIBG therapy 
(Monsieurs et  al 2002), despite the fact that the images obtained have been shown to be 
less sensitive in detecting lesions than post-therapy 131I-mIBG scans (Yang et al 2012). In 
response an alternative positron emission tomography tracer, 124I, has been used in attempts to 
improve diagnostic image quality and quantitative accuracy for dosimetry (Huang et al 2014, 
Koopmans et al 2014). As 124I-mIBG is not widely available and its clinical efficacy remains 
unproven, 123I-mIBG remains the standard.
Although 123I predominantly emits gamma photons at 159 keV (83% abundance), photons 
above 500 keV (2.3% abundance) are also emitted. These high energy photons penetrate the 
septa of low-energy (LE) collimators and down-scatter into the main photo peak energy win-
dow, producing background counts that reduce image contrast (Dobbeleir et al 1999). It was 
demonstrated almost 40 years ago that medium-energy general purpose (MEGP) collimators 
provide better signal detection than the a LE high-resolution (HR) collimators (Bolmsjo et al 
1977). A number of groups now recommend the use of MEGP collimators for 123I-mIBG 
imaging based on a qualitative assessment (Macey et al 1986, Dobbeleir et al 1999, Snay et al 
2011, Gelfand et al 2013). However the spatial resolution provided by a MEGP collimator 
is typically poorer than that provided by a LEHR collimator and its count sensitivity lower 
than its LE general-purpose (GP) counterpart. Consequently the choice of collimator may 
significantly impact upon image quality and ultimately interpretation of the 123I-mIBG study. 
Figure 1 demonstrates the difference in appearance of 10 min static scans for the same patients 
acquired with Philips’ high-resolution and MEGP collimators.
Whilst there are well established guidelines on the use of 123I-mIBG imaging in neuroblas-
toma and NET cases, explicit guidance with regard to collimator use is lacking. The choice of 
collimator is left to the discretion of the imaging centre (Olivier et al 2003, Bombardieri et al 
2010, Matthay et al 2010, Taieb et al 2012).
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The aim of this study was to determine which collimator optimises lesion detection on 
planar 123I mIBG images. The channelized Hotelling observer (CHO) model can be used to 
rapidly score larger sets of images than humans for the presence of an abnormality provid-
ing good statistical quality receiver operator characteristic (ROC) curves, that can be used 
to assess the efficacy of lesion detection for different imaging methods. This model has 
been shown to correlate well with human observers in lesion detection tasks and has been 
widely used in the optimization of several nuclear medicine imaging techniques (Hanley 
et al 1982, Gifford et al 2000, Gifford et al 2005, He et al 2010, El Fakhri et al 2011, Bal 
et al 2014, Yang et al 2014). In this study our implementation of the CHO model was first 
validated against human observations of 100 images for 2 collimators. The validated model 
was then applied to score 400 test images generated from 8 separate collimators from 3 
different manufacturers. ROC curves were produced from these scores for each collimator. 
The areas under the ROC curves were used to provide an objective measure of the lesion 
detectability. These values were compared to objectively demonstrate the collimator that 
optimised lesion detection.
Methods
Collimator design varies widely between manufacturers. Therefore collimators on a Discovery 
NMCT (GE), a Skylight gamma camera (Philips) and a Symbia Intevo Excel SPECT/CT 
(Siemens) were assessed (table 1). It should be noted that the Skylight camera had thicker 
crystals (5/8″) than the Discovery and Intevo (3/8″) models.
Collimator characterisation
Each collimator’s septal penetration fraction and system sensitivity were measured for 123I 
imaging in accordance with the NEMA standards (NEMA 2007).
Figure 1. Static images of a 7 year old child with metastatic neuroblastoma deposits A 
acquired with a high-resolution collimator then B with a MEGP collimator.
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Physiological background and lesion present patient image simulation with anthropomorphic 
phantoms
Images were created using an anthropomorphic phantom to simulate the clinical challenge of 
lesion detection for each collimator/camera combination.
The Liqui-Phil™ anthropomorphic abdomen-shaped phantom was filled with 9585 ml inac-
tive water. The dimensions of this phantom, indicated in figure 2, correspond to an older child 
or adult. The phantom contained an inactive 2.5 cm diameter polyoxymethylene cylinder to 
simulate the attenuation of the spine. Lesion-mimicking-inserts filled with 123I were posi-
tioned in the phantom at the positions shown in figure 2. These were a 2 cm diameter sphere 
adjacent to the anterior surface of the spine, a 3 cm diameter sphere near the centre of the 
liver and (1 mm internal diameter) Polyethylene tubing wrapped twice around the spinal cyl-
inder to represent a single mIBG avid vertebra. Three separate anterior and posterior pairs of 
planar scans were acquired with the abdomen-shaped phantom containing only one lesion at 
a time. In addition the Liqui-Phil™ liver insert filled with 123I was imaged separately within 
the abdomen-shaped phantom. Finally 123I was added to the abdomen-shaped phantom itself 
and it was imaged independently to produce an abdominal background image. The activity 
concentrations used for all inserts and the background are shown in figure 2. The phantom was 
positioned on the standard imaging couch. Planar scans were acquired with each collimator on 
each gamma camera with a 20% wide energy window centred on 159 keV, a 256  ×  256 matrix 
and uniformity correction. The uniformity correction on the Skylight was based on intrinsic 
123I maps, to correct for photon detector tube edge enhancement artefacts. No such artefacts 
were observed in these phantom images. This was not necessary for the other 2 systems and 
an extrinsic Cobalt-57 uniformity map was used. The pixel dimensions were 4.6  ±  0.2 mm2 as 
the detector field-of-view varies for each camera. The Siemens Intevo has the largest 614 mm 
FOV, the Philips Skylight has a 597 mm FOV and the GE Discovery has the smallest 565 mm 
Table 1. Collimator characteristics with NEMA septal penetration and system 
sensitivity.
Camera Collimator
Hole 
sizea 
(mm)
Septal 
thicknessa 
(mm)
Length 
(mm)
Spatial 
resolution 
(mm)a
Septal  
pen-etration 
%
System 
sensitivity (cps/
MBq)  ±  errorb
Discovery 
(GE)
MEGP 3.0 1.05 58.0 9.4 0.0 70.3  ±  1.2
LEHR 1.50 0.20 35.0 7.4 0.2 96.6  ±  1.7
Skylight 
(Philips)
MEGP 2.95 1.14 48.0 11.3 0.0 101.1  ±  1.9
LEHR 1.40 0.15 32.8 7.4 1.1 109.3  ±  2.1
LEGP 1.40 0.18 24.7 8.8 5.8 204.3  ±  3.9
Intevo 
(Siemens)
MELP 2.94 1.14 40.64 12.5 0.0 115.6  ±  0.5
LEHR 1.11 0.16 24.05 7.5 16.3 185.9  ±  0.9
LEAP 1.45 0.2 24.05 9.4 12.0 225.9  ±  1.0
MEGP/LP  =  medium-energy general purpose/low penetration, LEG/AP  =  low-energy general/all purpose and 
LEHR  =  low-energy high-resolution.
a Spatial resolution is supplied for collimated photons, as the FWHM at 10 cm from the collimator external surface 
in the manufacturers specification, for a 3/8″ crystal. The thicker (5/8″) Skylight crystal will provide poorer spatial 
resolution, however this value is not available from the manufacturer.
b Error propagated from the uncertainty in the measured activity and square root of the region of interest counts, 
used in the NEMA calculation of sensitivity.
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FOV. The collimator faces were positioned as close as possible to the phantom posterior 
and anterior surfaces. The objects were scanned for as long as possible depending on each 
camera’s availability. The frame duration used for each collimator image set was adjusted to 
account for the physical decay of the 123I between each image set, so that the image count sta-
tistics remained comparable. Therefore these high-count images reflect the relative variation 
in sensitivity, spatial resolution and septal penetration between the collimators. A minimum of 
3k counts was collected for the inserts and 347k counts for the abdomen. For each image set 
acquired the abdomen-shaped phantom position was accurately reproduced using markings 
on the camera couch.
The acquired images were combined using an interactive data language (IDL) (release 
8.2.3, ITT Visual Information Solutions) user script. This program first reduced the liver and 
abdomen image counts to values representing clinical image frame times between 400 and 
600 s. The count in each pixel was then randomly selected from a Poisson distribution, with a 
mean value set to the rescaled count. A different random seed was used to create 200 different 
statistical realisations of the liver and abdomen. These images were then summed to produce 
200 background images per collimator of the liver and physiological abdominal background 
images with liver-to-background ratios (LBR) ranging from 3.6 to 5.6.
For each collimator 200 images containing a low-contrast single-lesion were created by 
adding lesion-insert-images to the background images. The lesion-insert-image counts were 
rescaled prior to Poisson resampling to simulate varied tumour-to-background ratios (TBR). 
The tumour images were also shifted axially to simulate a variety of lesion locations. The 
resampled-shifted-lesion-insert images were then summed to the normal scans. In this way 
17 images with the 3 cm sphere in the liver, 79 with the 2 cm sphere next to the spine and 104 
images with a vertebra were created, all with different TBRs. The resulting liver-lesion TBRs 
ranged from 2.8 to 7.2, the spine-lesion TBRs were 29 to 255 and the vertebra TBRs were 
179–1785. The vertebra required a high TBR to be visible. The range of simulated activity 
Figure 2. A cross-section of the abdomen-shaped phantom. The positions and activity 
concentrations of the fillable inserts are shown. These were scanned individually within 
the abdomen shaped shell alongside the spine insert. The shell dimensions vary within 
the range indicated along the axial length of the phantom.
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concentrations are shown in table 2. These lesion-to-background activity concentration ratios 
and positions were chosen to provide a broad range of challenging lesion detection tasks, from 
clearly visible to barely perceivable lesions.
A total of 3200 posterior images were used for CHO scoring. The resultant average signal-
to-noise ratios (SNR) in 3 cm circular ROIs in the hottest part of the liver and coldest part of 
the background were compared to those measured in 6 recent patient scans. Three of these 
10 min static patient scans were acquired with MEGP collimators and 3 were acquired with 
LEHR collimators. The SNR was calculated as the mean divided by the standard deviation in 
the mean ROI counts.
Channelized Hotelling observer
A mathematical model, the channelized Hotelling observer (CHO) was used to score the 
images for the possibility of an abnormality. The CHO model was written in IDL following 
the method published by Shidahara et al (2006). Test statistics were produced from the Fourier 
transformed images, F(ρ), filtered into different frequency channels. These channels have a 
psychophysiological basis in reflecting the frequency selective channels of the human visual 
system. Radially symmetric channels were applied in the frequency domain, described by;
( ) ∥ ∥ [ ]
 
⎧⎨⎩ρ
ρ ρ ρ= ∈
−
u 1 2 , 2
0 Otherwise
,
c c
c
0
1
0 (1)
where { }∈c 1, 2, 3, 4, 5  ρ0 pixel−1 is the low end cut-off frequency. The average value in each 
channel was calculated to create a matrix of values, ri, for each of the 5 channels, i, r  =  [r1, 
r2, r3, r4, r5] for each image f. The difference of the means of the channel matrices per camera-
collimator combination, for the lesion present ra and lesion absent rn channel matrices were 
used to define a matching filter −r ra n.
Pre-whitening was used to de-correlate the noise in the channels by multiplication with 
−K 1, which is the inverse of the average of the 2 noise covariance matrices for the entire abnor-
mal and normal ensemble. Then a test statistic λf for each image was calculated as;
[ ]λ = − −r r K r.f a n T 1 (2)
In effect CHO provides a score for the possibility of a lesion presence, as the weighted sum of 
the counts in the frequency channels of the tested image.
Channelized Hotelling observer validation
In order to validate the CHO model, 4 experienced human observers scored 240 of the 
posterior phantom images for the presence of a lesion, using the scoring system in table 3. 
The observers were 2 medical physicists and 2 radiologists all with over 10 years’ experi-
ence at interpreting nuclear medicine scans. The images consisted of 60 of the background 
Table 2. Simulated activity concentration ranges in the resampled phantom images.
Object Simulated Range (kBq ml−1)
Abdomen 0.53–0.79
Liver 1.6–2.4
3 cm sphere in liver 36–143
2 cm sphere by spine 23–202
Vertebra 1000–7000
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and 60 images containing lesion inserts generated for each of the Philips LEHR and MEGP 
collimators. These were viewed on the Hermes work station (Hermes Medical Solutions) 
that all the observers were familiar with. The images from the different collimators were 
randomly interspersed so the observers were not informed of the collimator used. The first 
20 images from each collimator were used as training sets as the observer learnt the scoring 
system and adjusted their own criteria to apply it. The following 100 images were used to 
form ROC curves. For each score for each of the background and lesion present images, the 
fraction of the scores equal to and above a threshold score was calculated. The threshold 
that was used to assign an image as positive or negative for the presence of a lesion, was 
incremented from the lowest to the highest score (1–5). The true positive fraction (TPF) 
was calculated from the lesion present images and the false positive fraction (FPF) was 
calculated from the background images. The average TPF and FPF for each human score 
threshold was used to create an average human ROC curve against which the CHO curves 
were compared.
CHO was used to score the same 100 (non-training) images for each collimator. CHO 
scores were binned into 12 score thresholds equally covering the range of scores generated 
by CHO for each data set. This gave comparable discrete FPF sampling frequency for the 
CHO and human ROC curves for validation. The area under these ROC curves, Az, was then 
calculated using a trapezoidal method. Standard deviations on the data points were calculated 
according to Metz (Metz 1978). These standard deviations were propagated to estimate errors 
on the area under the ROC curves. The CHO cut-off frequency was adjusted to achieve the 
best agreement between the CHO and average human observer Az. The validated cut-off fre-
quency was used for the further comparison of collimators.
Collimator lesion detectability comparison
The full set of 3200 posterior anthropomorphic phantom images was scored using the valid-
ated CHO model with the optimised cut-off frequency. The anterior images were discarded 
as neither observer was able to identify the lesions in the images leading to ineffectual ROC 
curves with an Az of 0.5.
The 400 CHO scores for each collimator were used to generate ROC curves for near con-
tinuous thresholds using ROCkit 0.9B (Metz 1998). This software also fitted a binormal dis-
tribution to the ROC curve, calculated Az, compared the correlated ROC curves and provided 
a two-tailed p-value to quantify the statistical significance of the difference between them. It 
had not been possible to apply this software to the human scores due to limited number of data 
points associated with the 5 human scores.
Table 3. Human observer scoring system.
Score Decision
1 Definitely normal
2 Probably normal
3 Equivocal
4 Maybe abnormal
5 Definitely ab normal
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Results
Collimator characterisation
Table 1 shows the NEMA test results alongside the other collimator properties. No septal 
penetration was found for any of the medium-energy collimators. The long thick septa of 
these collimators appeared to stop the high energy photons. However the ME collimators were 
the least sensitive for each camera. The LEGP collimators were the most sensitive and gave 
double the sensitivity of the MEGP collimators but with over 5% septal penetration. The most 
septal penetration (16.3%) occurred for the Siemens LEHR collimator which has the short-
est thin septa of all the collimators tested. Star artefacts were evident in the images from this 
collimator. The septal penetration of the Siemens’ LEHR collimator was 15 times higher than 
that of the Philips, due to the shorter Siemens’ collimator holes. The GE collimators provided 
the lowest septal penetration of the three manufacturers.
The sensitivity between camera collimators could not be compared because the thicker 5/8″ 
crystal of the Skylight (Philips) will bias these sensitivity results.
Physiological Background and Lesion Present Patient Image Simulation with Anthro­
pomorphic Phantoms
Images before and after Poisson resampling are shown in figure 3. These are inset on a plot of 
a single pixel wide profile across the vertebra insert.
The resultant simulated total image counts ranged from 245k to 378k counts, which are typical 
of those acquired from 10 min abdominal mIBG planar scans. Examples of the generated images 
are shown in figure 4. The average pixel count in the background of the 6 patient scans was 20  ±  5 
compared to 15  ±  5 in the background of the phantom scans. The average liver counts were 45  ±  7 
and 30  ±  8 in the patient and phantom images respectively. The average liver-to-background ratio 
(LBR) counts were 2.26  ±  0.89 and 1.96  ±  1.59 in the patient and phantom images respectively. 
The SNR in the patient images background was 4.16  ±  0.59 and the liver was 6.49  ±  1.38. In the 
phantom images the SNRs were 3.47  ±  0.36 in the background and 4.73  ±  0.44 in the liver. All 
errors on these values are the standard deviations in the means. The count densities and SNRs 
were therefore lower in the phantom than the patient images, but a similar order of magnitude.
Figure 3. An example of a high count image prior to Poisson resampling left, with a 
profile through the insert image overlaying the spine to mimic one active vetebra. The 
image on the right is the same geometry following Poisson resampling.
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Channelized Hotelling observer validation
The least difference between the human observer and CHO ROC Az scores was observed at 
a low end cut-off frequency of 0.008 pixel−1. This was the lowest achievable frequency at 2 
per 256 pixels. This value of ρ0 was used for all subsequent CHO experiments. The validation 
ROC curves are shown in figure 5, the areas under these ROC curves are shown in table 4. The 
values are within the standard errors of one another.
Collimator lesion detectability comparison using receiver operator characteristic curves
The ROC curves generated using CHO from 200 normal and 200 abnormal images for each 
collimator are shown in figure 6. The LEHR ROC curves consistently demonstrated lower 
TPF values than for the GP curves indicating poorer lesion detectability with LEHR collima-
tors than for the other collimators.
The areas under these curves are given in table  5. On average the LEHR collimators 
resulted in smaller Azs of 0.891  ±  0.004 than 0.933  ±  0.004 for the MEGP collimators. 
This difference was statistically significant (p  <  0.05) see table 6. There was no statistically 
significant difference between the Philips LEGP and LEHR collimators. However there was a 
statistical difference between the Az for the equivalent Siemens collimators. In contrast there 
Figure 4. Example abnormal posterior images from the Skylight (Philips) gamma 
camera, corresponding to each of the available collimators.
Figure 5. CHO with a 0.008/cycle cut-off frequency versus the average human ROC 
curves for (a) the LEHR and (b) MEGP posterior images generated for the Philips 
Skylight gamma camera. The errors on the human curves are the standard deviation in 
the FPFs and TPFs.
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was a statistically significant difference between the Philips MEGP and LEGP collimators but 
not for the corresponding Siemens collimators.
Discussion
Eight collimators from the three major manufacturers were characterised and assessed for 
123I imaging in this study. These cover the majority of the collimators currently used for 123I 
imaging. Collimators designed specifically for 123I imaging are not in wide use and were not 
available for this study.
Septal penetration was measured for all the low-energy collimators. The Siemens LEHR 
collimators gave the highest levels of 16.3% septal penetration. At acceptance testing of the 
Intevo system (Siemens) it was noted that this collimator similarly suffered from high (9.4%) 
septal penetration with Tc-99m. This may be expected as the Siemens LEHR collimators have 
the smallest holes and shortest thin septa of the collimators tested.
Table 4. CHO Validation (120 images for each collimator): areas under the ROC curves 
(figure 5) Az  ±  standard error.
Collimator Human CHO
MEGP 0.89  ±  0.11 0.93  ±  0.12
LEHR 0.92  ±  0.11 0.87  ±  0.12
Figure 6. The binormal fit to the ROC curves for each manufacturer and tested 
collimator.
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The MEGP collimators allowed no measurable septal penetration, therefore the count rates 
did not vary with source-collimator distance. Future work will investigate the optimal protocol 
for quantitative imaging to provide standard uptake values for early assessment of treatment 
response and dosimetry calculations. Quantification should be simpler using MEGP collima-
tors as the counts did not vary with source-collimator distance. The count rates for the low-
energy collimators did vary with this distance due to septal penetration, so the quantitative 
accuracy for these images would vary with the activity distribution. Therefore benefits from 
using MEGP over low-energy collimators for quantitative imaging are expected and have been 
demonstrated for cardiac imaging (Inoue et al 2003).
The areas under the CHO and human ROC curves agree within the standard errors of each 
other. Therefore the CHO model was successfully validated against human scoring (figure 5 
and table 4). The smallest possible low end cut-off frequency (0.008 pixels−1) for a 256 matrix 
gave the best agreement between the CHO and human observer areas under the ROC curves, 
Az. This corresponds to scoring images at the lowest usable 5 frequency bands, where statisti-
cal noise is effectively filtered. Therefore the variations in count concentrations correspond to 
structural rather than statistical changes. The human observer would also concentrate on these 
lower frequencies to identify structures, such as lesions. Therefore this finding is as expected.
The areas under each of the collimator’s human ROC curves were similar at 0.92  ±  0.11 
and 0.89  ±  0.11 for the MEGP and LEHR collimators respectively. However ROCkit could 
not be used to fit a ROC curve to the human’s scores, due the limited number of data points. 
The ROC curve trapezoidal Az was therefore calculated manually. These curves were not com-
pared to assess the statistical significance of the difference in Az between the collimators from 
human scores. However the overlapping error intervals on the areas under the ROC curves in 
table 4 indicate the difference in Az between collimators is insignificant.
Table 5. CHO collimator comparison (400 images for each collimator): areas under the 
ROC curves (figure 6) Az  ±  standard error.
Manufacturer Collimator Az
GE MEGP 0.932  ±  0.013
LEHR 0.894  ±  0.016
Philips MEGP 0.937  ±  0.012
LEHR 0.893  ±  0.016
LEGP 0.903  ±  0.016
Siemens MELP 0.929  ±  0.015
LEHR 0.887  ±  0.017
LEAP 0.920  ±  0.014
Table 6. Two tailed p-values of correlation between collimators Az.
Manufacturer Collimators p-value
GE MEGP versus LEHR 0.029
Philips MEGP versus LEHR 0.012
LEHR versus LEGP 0.657
MEGP versus LEGP 0.039
Siemens MELP versus LEHR 0.005
LEHR versus LEAP 0.011
MELP versus LEAP 0.563
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The ROC curves for CHO achieved from large image sets (200) of images per collimator 
provided improved statistical quality ROC curves compared to that attained with an ensemble 
of 50 images and human scores. The low errors on the Az from these ROC curves allow dem-
onstration of the significant differences in Az for some of the collimators with confidence in 
2-tailed p-values less than 0.05 (table 6). The variations in collimator and couch designs and 
pixel size between the manufacture’s systems led to a 5% range in Az, of 0.05 compared to 
the average Az of 0.91.
CHO scores are based on the counts within the low frequency channels. The CHO ROC 
curves obtained from the MEGP collimators were consistently highest due to the larger num-
ber of low frequency counts in the MEGP images corresponding to lesions (figure 6). Septal 
penetration causes a higher proportion of counts from the lesions to appear at higher fre-
quencies within the LEHR collimator images, which additionally increases the image noise 
and reduces image contrast. Therefore the areas under the ROC curves (table 5) objectively 
demonstrate improved lesion detectability with MEGP compared to LEHR collimators, due to 
these factors. These results are in agreement with published findings that MEGP collimators 
demonstrate improved 123I image quality (Bolmsjo et al 1977, Snay et al 2011, Gelfand et al 
2013). The improvement in lesion visibility with general purpose collimators is also evident 
in the example images of figure 3.
A limitation of this work was that test data were necessarily generated from phantom 
images, as it is impractical to acquire 200 patient images of normal physiology and 200 images 
with a single lesion on multiple systems. The solution in this study was to simulate these using 
Poisson resampled phantom images. The generated images in figure 3 have similar appear-
ance to the abdominal region of figure 1. Although the count densities and SNRs are lower 
in the phantom-based simulations than in the average patient images, they are the right order 
of magnitude and therefore realistic. The liver-to-background ratios were varied to simulate 
the physiological differences in patients and were on average similar to those measured in a 
sample of clinical scans. However using the phantoms available for this study it was not pos-
sible to simulate variations in patient geometries. Therefore the training images were similar 
to those used to produce the ROC curves.
This assessment was performed for static scans as lesions tend to be identified on planar 
images and these images may be used for disease staging alone. If SPECT images are used 
the lesions are first located in the planar scans to identify the region where the SPECT scan 
is performed. These 3D images are then generally used to confirm the lesion location after 
it has been detected (Barwick et al 2010). This work may be extended to optimise the many 
acquisition and reconstruction parameters for SPECT imaging to improve lesion detection and 
therefore localisation.
Conclusions
In this study a channelized Hotelling observer model was developed, validated and used to 
objectively quantify lesion detectability as the area under ROC curves. This demonstrated 
that the benefit of reduced background noise, provided by the general-purpose collimators, 
outweighs the benefit of the superior spatial resolution of LEHR collimators for mIBG avid 
lesion detection using 123I mIBG planar images.
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